Importantly, increased LEF1 is also observed in latent-EBV-associated cancers including Burkitt lymphoma, nasopharyngeal carcinoma, and gastric carcinoma [42–44]. The gene discussed is LEF1; the disease is nasopharyngeal carcinoma.